Drugs for Mycobacteria Flashcards

1
Q

Isoniazid, Rifampin, Pyrazinamide and Ethambutol are first line drugs for this condition

A

Tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

First line drug for tuberculosis that inhibits lipid (mycolic acid) synthesis required for cell wall integrity

A

Isoniazid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MOA of Isoniazid

A

Inhibits mycolic acid synthesis required for cell wall integrity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Isoniazid is inactivated by genetically determined ______

A

Acetylation
(Acetyl isoniazid may be converted to acetyl hydrazide, then to a hepatotoxic metabolite)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Tuberculosis drug that is inactivated by genetically determined acetylation

A

Isoniazid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Neurotoxicity from Isoniazid may be minimized by administration of this

A

Pyridoxine (vit b6)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pyridoxine (B6) may minimize this adverse effect of Isoniazid

A

Neurotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pyridoxine (B6) may minimize neurotoxicity of this tuberculosis drug

A

Isoniazid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

High acetylators have higher risk of this adverse effect of Isoniazid

A

Hepatotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Isoniazid use should be avoided if there is a five fold increase in this in normal individuals or three fold increase in patients with symptoms of hepatitis

A

Serum aspartate aminotransferase (AST)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Neurotoxicity, hepatotoxicity, and hemolysis in patients with G6PD deficiency are adverse effects of this tuberculosis drug

A

Isoniazid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Primary toxicity of Ethionamide

A

Neurological disruption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tuberculosis drug with neurological disruption as a primary toxicity

A

Ethionamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tuberculosis drug that inhibits arabinogalactan polymerization by inhibition of arabinosyl transferase, thereby disrupting cell wall synthesis

A

Ethambutol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ethambutol inhibits this enzyme

A

Arabinosyl transferase
thus inhibits arabinogalactan polymerization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Retrobulbar neuritis (visual defects that are usually reversible, including loss of central vision, impaired red/green discrimination, and constriction of peripheral vision) is a characteristic adverse effect of this tuberculosis drug

A

Ethambutol

17
Q

Primary adverse effect of Ethambutol

A

Retrobulbar neuritis (visual defects)

18
Q

MOA of rifamycins

A

Inhibit DNA-dep RNA pol

19
Q

Tuberculosis drug that inhibits DNA-dep RNA pol

A

Rifamycin

20
Q

Tuberculosis drug that can induce microsomal enzymes systems (high risk of drug interactions)

A

Rifamycin

21
Q

Tuberculosis drug where half life will fall during early stages of therapy due to autoinduction

A

Rifamycin

22
Q

Tuberculosis drug that has increased risk of hepatotoxicity when given with isoniazid

A

Rifamycin

23
Q

Tuberculosis drug with immunosuppressive effects, most common with intermittent therapy, early flu-like symptom

A

Rifamycin

24
Q

Is Pyrazinamide safe in pregnancy?

A

Not recommended; effect on fetus unknown

25
Q

Hepatotoxicity related to dose and duration of treatment, and Hyperuricemia are adverse effects of this tuberculosis drug

A

Pyrazinamide

26
Q

Hyperuricemia is an adverse effect of this tuberculosis drug

A

Pyrazinamide

27
Q

2 main adverse effects of Pyrazinamide

A

Hepatotoxicity
Hyperuricemia

28
Q

2 Tuberculosis drugs that inhibit dihydropteroate synthase to block folate synthesis

A

Para-Aminosalicylic acid and Dapsone

29
Q

MOA of Para-Aminosalicylic acid

A

Inhibits dihydropteroate synthase to block folate synthesis

30
Q

Sodium overload is a concern for this tuberculosis drug as oral preps are very high in sodium

A

Para-Aminosalicylic acid

31
Q

This is a concern with Para-Aminosalicylic acid oral preps

A

Sodium overload

32
Q

Tuberculosis drug with similar structure to Alanine, acts as a competitive inhibitor of Alanine racemase, blocks incorporation of D-ala into cell wall components

A

Cycloserine

33
Q

MOA of cycloserine

A

Similar structure to alanine
Competitive inhibitor of alanine racemase
Blocks incorporation of D-alanine into cell wall components

34
Q

2 main adverse effects of cycloserine

A

Neurological effects
Hemolysis in patients with G6PD deficiency

35
Q

MOA of Dapsone

A

Inhibits folic acid synthesis by inhibiting dihydropteroate synthase

36
Q

Characteristic hypersensitivity reaction of Dapsone involving fever, malaise, exfoliative dermatitis, jaundice and hepatic necrosis

A

Sulfone syndrome

37
Q

Characteristic hypersensitivity reaction involving fever, malaise, exfoliative dermatitis, and juandice and hepatic necrosis is an adverse effect of this tuberculosis drug

A

Dapsone

38
Q

6 month TB treatment regimen involves these 4 drugs during the intensive phase

A

“RIPE”
Rifamycin
Isoniazid
Pyrazinamide
Ethambutol